Search results for “Angiofibroma” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 86 patents, we discovered top 17 key players by total patent application. Centro de Ingenieria Genetica y Biotecnologia, Schering AG, Ono Pharmaceutical Co., Ltd. are dominant in this area. They take 53.49% of the total patent filing.
HAVANA, Cuba
Patent: 19
Berlin, Germany
Patent: 15
Osaka-fu, Japan
Patent: 12
Berlin, Germany
Patent: 11
Connecticut, United States
Patent: 8
STOCKHOLM, Sweden
Patent: 3
United States
Patent: 3
California, United States
Patent: 1
United States
Patent: 1
Berlin, Germany
Patent: 1
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 13 patents applied in the last 5 years. We discover 4 most active companies in this area. The fast-growing AI Therapeutics, Al Therapeutics Inc, The Board of Regents of The University of Texas System take 76.92% of patent filing during this period.
Connecticut, United States
Patent: 7
United States
Patent: 2
The Board of Regents of The University of Texas System
Texas, United States
Patent: 1
Sichuan Sheng, China
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 13 patents in last 5 years, we discover 1 new entrants.
Sichuan Sheng, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
No data, please try another search term
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: